Evaluation of drug mechanism and efficacy of a novel anti-angiogenic agent, ttac-0001, using multi-modality bioimaging in a mouse breast cancer orthotopic model

HIGHLIGHTS

• who: Jinil Kim and collaborators from the Department of Radiology and the Research Institute of Radiology, University of Ulsan College of Medicine have published the Article: Evaluation of drug mechanism and efficacy of a novel anti-angiogenic agent, TTAC-0001, using multi-modality bioimaging in a mouse breast cancer orthotopic model, in the Journal: PLOS ONE | https://doi.org/10.1371/journal.pone [0187063]. January 25, 2018 of /1371/
• what: The authors aimed to elucidate the drug mechanism and anti-tumor efficacy of a novel fully human anti-VEGFR-2/KDR monoclonal antibody in mouse . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.